PLANTS RESISTANT TO TOSPOVIRUSES

Abstract: The present invention provides, inter alia, a recombinant polynucleotide, comprising a transcriptional regulatory region and a region contiguous therewith and under the transcriptional control thereof, wherein the contiguous region comprises the sequence depicted in SEQ ID No. 1 or a sequence complementary thereto or a part of the sequence or complement, characterized in that the sequence, complement or part is modified (i) by removal therefrom of translational-start encoding codons, or mutation of such codons so that they do not encode translational start or stop codons; or (ii) by insertion or deletion of nucleotides 3' of the translational start encoding codon so that the translational reading frame of the thus encoded RNA is different to that of the unmodified sequence, complement or part. The modified sequence, complement or part is capable of conferring upon plants resistance or tolerance to tospoviruses - typified by TSWV.

Description: plants resistant to tospoviruses The tospoviruses are a group of negative-strand I-INA viruses, which form a separate genus within the arthropod-borne family of Bunyaviridae and are unique within this family with respect to their ability to infect plants. Based on serological differences and sequence divergence of the nucleoprotein gene, four different tospovirus species have so far been established: tomato spotted wilt virus (TSWV), tomato chlorotic spot virus (TCSV), groundnut ringspot virus (GRSV), .and impatiens necrotic spot virus (INSV). Based on serological data, groundnut bud necrosis virus, watermelon silver mottle virus -and groundnut yellow spot virus have been proposed as additional members of the Tospovirus genus. Tospoviruses are the only plant viruses that are transmitted by thrips species in a propagative manner. The type species of the genus Tospovirus, TSWV, has a very broad host range, encompassing more than 650 plant species within 70 families, including many important crops and ornamentals. The TSWV particle consists of a nucleocapsid core, in which the genomic RNAs are tightly associated with the nucleoprotein (N), surrounded by a lipid membrane containing two types of glycoprotein-protrusions Gl and G2. In addition, several copies of the putative viral RNA-dependent RNA polymerase are present in the virus particle. The complete nucleotide sequence of the three genomic RNAs of TSWV has been determined. The L RNA is of complete negative polarity and encodes the putative viral polymerase of 331.5 lcilodalton (kD). The M and S RNAs both have an ambisense coding arrangement and are translated from subgenomic messenger RNAs. The M RNA codes for the precursor of the membranέ glycoproteins Gl and G2 (of 78 kD and 58 kD respectively) and a non-structural protein (NS M ) of 33.6 kD, which represents the putative viral movement protein. The S RNA codes for the N protein of 28.8 kD and another non-structural protein (NS S ) of 52.4 kD. When compared to coding arrangements of the genomic RNAs of other members of the family Bunyaviridae, tospoviruses are unique in having an ambisense M RNA segment. The additional presence of the NS M gene on the viral strand seems to be an evolutionary adaptation of Bunyaviridae to the pl-ant kingdom. It has been proposed that the NS M gene product enables the virus to pass the cell wall boundary, suggesting NS M to represent the viral cell-to-cell movement protein. Engineered resistance to tomato spotted wilt tospovirus (TSWV) has been accomplished previously by expressing the viral nucleoprotein (N) gene in transgenic tobacco. Recently, engineered TSWV resistance has been introduced in tomato plants and tomato hybrids. Similar levels of protection, i.e. complete immunity to the virus in homozygous S2 plants, have been observed when an untranslatable N gene was expressed, indicating that the N gene-based resistance is, at least for a major part, RNA-mediated. Besides tospoviral nucleoprotein and positive strand RNA virus coat protein sequences, other, non-structural gene sequences have been used to confer engineered virus resistance, including replicase and protease genes. The present invention provides, inter αliα, recombinant nucleotide sequences based on those encoding the Tospovirus M RNA which are useful in rendering plants tolerant or resistant to tospoviral infections. By "resistant" is meant a plant which exhibits substantially no phenotypic changes as a consequence of infection with the virus. By "tolerant" is meant a plant which, although it may exhibit some phenotypic changes as a consequence of infection with a virus, does not have a substantially decreased reproductive capacity or substantially altered metabolism. According to the present invention there is provided a recombinant polynucleotide, comprising a transcriptional regulatory region and a region contiguous therewith and under the transcriptional control thereof, wherein the contiguous region comprises the sequence depicted in SEQ ID No. 1 or a sequence complementary thereto or a part of the sequence or complement, characterized in that the sequence, complement or part is modified (i) by removal therefrom of translational-start encoding codons, or mutation of such codons so that they do not encode translational start or stop codons; or (ii) by insertion or deletion of nucleotides 3 * of the translational start encoding codon so that the translational reading frame of the thus encoded RNA is different to that of the unmodified sequence, complement or part. By "part" is meant a sequence cont^ed within the contiguous sequence of the recombinant polynucleotide according to the invention, .and having at least 80 nucleotides. More preferably the part has at least 150 nucleotides, and still more preferably the part has at least 400 nucleotides. In the case that the translational start encoding codon is rendered non functional, it is preferred that the said mutation consists of base replacement. It is preferred that the contiguous region consists of nucleotides 3813 to 4721 in SEQ ID. No. 1 or the complement thereof or a part of the sequence or complement. The invention also includes recombinant polynucleotides wherein in the contiguous region, the sequence depicted in SEQ ID No. 1 from nucleotides 3813 to 4721 has been modified so as to comprise codons other than those present in the unmodified sequence, with the proviso that in the modified sequence, the amino acids specified by such codons are the same as those specified by the codons in the un-modified sequence. The invention further includes a nucleotide sequence which is complementary to one (hereinafter "test" sequence) which hybridizes under stringent conditions with the contiguous region of the said polynucleotides, as well as RNA which is encoded by the said contiguous region or nucleotide sequence. When the hybridization is performed under stringent conditions, either the test or inventive sequence is preferably supported. Thus either a denatured test or inventive sequence is preferably first bound to a support .and hybridization is effected for a specified period of time at a temperature of between 55 and 70 * C in double strength citrate buffered saline containing 0.1%SDS followed by rinsing of the support at the same temperature but with a buffer having a reduced SC concentration. Depending upon the degree of stringency required such reduced concentration buffers are typically single strength SC containing 0.1%SDS, half strength SC containing 0.1%SDS and one tenth strength SC containing 0.1%SDS. The invention still further includes: a DNA construct comprising the said polynucleotide or nucleotide sequence; a biological vector comprising the said polynucleotide, nucleotide sequence, or construct; and plant cells containing the polynucleotide, nucleotide sequence, construct, or vector. The invention still further includes a method of rendering pl-ants resistant or tolerant to infection by tospoviruses comprising the steps of transforming regenerable plant material with a recombinant polynucleotide comprising a transcriptional regulatory region and a region contiguous therewith and under the transcriptional control thereof and regenerating the thus transformed material into morphologically normal plants, characterized in that the recombinant polynucleotide comprises as its contiguous sequence, the sequence depicted in SEQ ID No. 1 or a sequence complementary thereto or a part of the sequence or its complement. It is more preferred that the contiguous sequence comprises the sequence depicted in SEQ ID No. 1 or a sequence complementary thereto or a part of the sequence or complement, which is modified (i) by removal therefrom of translational-start encoding codons, or mutation of such codons so that they do not encode translational start or stop codons; or (ii) by insertion or deletion of nucleotides 3' of the translational start encoding codon so that the translational reading frame of the thus encoded RNA is different to that of the unmodified sequence, complement or part (as indicated above). Such a modified sequence may further contain the other modifications indicated above with respect to length and altered codon usage. The said normal fertile plants which result from the method indicated in the immediately preceding paragraph may be selfed to yield products from which are selected those which exhibit resistance or tolerance to tospoviral infection thereby yielding a substantially homogeneous line with respect to this trait. Individuals of the said line, or the progeny thereof, may be crossed with plants which optionally exhibit the said trait. In a particular embodiment of the method, the selfing and selection steps are repeated at least five times in order to obtain the homogeneous line. The contiguous region may be bounded by a plant effective transcriptional promoter and terminator, wherein the promoter and terminator control transcription of the sequence or complement when it is incorporated into a plant genome. Whatever recombinant sequence according to the invention it is intended to introduce into plants, such introduction may be via a bacterial or viral vector, by micro-injection, by co-incubation of the plant material and polynucleotide, sequence or construct in the presence of a high molecule weight glycol, or by coating of the polynucleotide, sequence or construct onto the surface of biologically inert particle which is then introduced into the material. The invention still further includes the use of a recombinant polynucleotide comprising the sequence depicted in SEQ LD No. 1 or a sequence complementary thereto or a part of said sequence or complement in the manufacture of virus resistant or tolerant plants. It is more preferred that the contiguous sequence comprises the sequence depicted in SEQ ID No. 1 or a sequence complementary thereto or a part of the sequence or complement, which is modified (i) by removal therefrom of translational-start encoding codons, or mutation of such codons so that they do not encode translational start or stop codons; or (ii) by insertion or deletion of nucleotides 3' of the translational start encoding codon so that the translational reading frame of the thus encoded RNA is different to that of the unmodified sequence, complement or part (as indicated above). Such a modified sequence may further contain the other modifications indicated above with respect to length and altered codon usage. The invention still further includes a virus tolerant or resistant plant having stably integrated and expressed within its genome, a recombinant polynucleotide comprising the sequence depicted in SEQ ID No. 1 or a sequence complementary thereto or a part of said sequence or complement. It is more preferred that the contiguous sequence comprises the sequence depicted in SEQ ID No. 1 or a sequence complementary thereto or a part of the sequence or complement, which is modified (i) by removal therefrom of translational-start encoding codons, or mutation of such codons so that they do not encode translational start or stop codons; or (ii) by insertion or deletion of nucleotides 3' of the translational start encoding codon so that the translational reading frame of the thus encoded RNA is different to that of the unmodified sequence, complement or part (as indicated above). Such a modified sequence may further contain the other modifications indicated above with respect to length and altered codon usage. Virus resistant or tolerant plants according to the invention include field crops, vegetables and fruits including tomato, pepper, melon, lettuce, cauliflower, broccoli, cabbage, brussels sprout, sugar beet, corn, sweetcorn, onion, carrot, leek, cucumber, tobacco, alfalfa, aubergine, beet, broad bean, celery, chicory, cow pea, endive, gourd, groundnut, papaya, pea, peanut, pineapple, potato, safflower, snap bean, soybean, spinach, squashes, sunflower, sorghum, water-melon and the like; and ornamental crops including Impatiens, Begonia, Petunia, Pelargonium, Viola, Cyclamen, Verbena, Vinca, Tagetes, Primula, Saint Paulia, Ageratum, Amaranthus, Anthirrhinum, Aquilegia, Chrysanthemum, Cineraria, Clover, Cosmo, Cowpea, Dahlia, Datura, Delphinium, Gerbera, Gladiolus, Gloxinia, Hippeastrum, Mesembryanthemum, Salpiglossis, Zinnia, and the like. The invention still further includes the progeny of above mentioned plants, which contain the contiguous sequence stably incorporated and hereditable in a Mendelian manner, and/or the seeds of such plants or such progeny. The skilled man will recognize that the invention thus includes the use of the above mentioned plants or seeds or progeny in the manufacture of all plants, including varieties. The invention still further includes a microbiological process of making virus tolerant or resistant plants, including varieties thereof, comprising the steps of: (i) transforming regenerable plant material with a recombinant polynucleotide and regenerating the thus transformed material into morphologically normal fertile plants; and (ii) optionally crossing the plants resulting from (i) with plants which are not the product of (i); characterized in that the recombinant polynucleotide comprises the sequence depicted in SEQ ID No. 1 or a sequence complementary thereto or a part of the sequence or its complement. It is more preferred that the contiguous sequence comprises the sequence depicted in SEQ ID No. 1 or a sequence complementary thereto or a part of the sequence or complement, which is modified (i) by removal therefrom of translational-start encoding codons, or mutation of such codons so that they do not encode translational start or stop codons; or (ii) by insertion or deletion of nucleotides 3' of the translational start encoding codon so that the translational reading frame of the thus encoded RNA is different to that of the unmodified sequence, complement or part (as indicated above). Such a modified sequence may further contain the other modifications indicated above with respect to length and altered codon usage. In a particular embodiment of the process, the said normal fertile plants are selfed to yield products from which are selected those that exhibit resistance or tolerance to tospovir^ infection thereby yielding a substantially homogeneous line with respect to this trait. Individuals of the said line, or the progeny thereof, may be crossed with plants optionally exhibiting the said trait. It is preferred that the selfing and selection steps are repeated at least five times in order to obtain the homogeneous line. By "microbiological process" is meant any process involving or performed upon or resulting in microbiological material and thus includes a process consisting of a succession of steps at least one of which steps is micro-biological. Transformation of plant material with inter alia, viral, and bacterial vectors (Agrobacterium tumefaciens for example), nucleic acid coated particles, and nucleic acid per se (optionally suspended in a high molecular weight glycol) are all microbiological processes. The invention will be further apparent from the following description taken in conjunction with the associated Sequence Listing and Figures. The Ex-ample demonstrates that high levels of resistance of plants to the negative-strand tomato spotted wilt virus are obtained in transgenic tobacco expressing sequences derived from the putative viral movement protein gene, NS M , which is encoded by nucleotides 3813 to 4721 in the sequence depicted in SEQ ID No. 1. In the Sequence Listing: SEQ ID. No. 1 shows the DNA sequence complementary to one which encodes the tospoviral M-RNA sequence which itself encodes the putative viral movement protein, in this case from tomato spotted wilt virus; SEQ ID. No. 2 shows sequence of the primer designated as Zup051 encoding the sequence from nucleotides 108 to 129 of the viral M RNA; SEQ ID. No. 3 shows the sequence of the primer designated as Zup014 encoding the sequence from nucleotides 3779 to 3800 of the viral complementary M RNA; SEQ ID. Nos. 4 and 5 show the duplex of the EcoRl/BamHl linker ligated to the sequence shown in SEQ ID No. 2. Of the Figures: Figure 1 shows the construction of plant transformation vectors pTSWV NS M -A, pTSWV NS M -B and pTSWV NS M -C. NS M sequences are amplified from a genomic cDNA clone of TSWV, using primers that added a BamHI restriction site to the 3' end of the gene (Zup014) and a EcoRI site immediately downstream of the original startcodon (Zup051). An oligonucleotide linker sequence containing an in frame s utcodon is ligated to the 5' end of the PCR fragment, thereby restoring the NS M ORF. Directly upstream of the ATG a unique Kpnl site is present. This fragment is inserted in the BamHI site of a pUC18 vector, resulting in a PstI site 3 * of the NS M sequence. By treating Kpnl linearised DNA with T4 DNA polymerase, blunt ends are created to which PstI linkers are ligated prior to cloning the NS M gene as a PstI fragment in the PstI site of the pZU-A plasmid in both sense (A) and anti-sense orientation (C), in the pTSWV NS M -A construct, the pZU-A vector had been previously supplied with TMV translation enhancing sequences upstream of the cloning site. Incubation with T4 DNA polymerase for a longer time at an elevated temperature results in the removal of extra nucleotides by the exonuclease activity of T4 DNA polymerase: these extra nucleotides included the A residue of the NS M startcodon. Ligation of a PstI linker yields an ATG-deficient NS M sequence, which is hence not translatable (B). After cloning in the PstI site of the pZU-A vector, the NS M sequences are supplied with a CaMV 35S promoter at the 5' end and flanked at their 3' ends by a nopaline synthase terminator. Finally, all three NS M constructs are cloned in the Kpnl and Smal sites of binary vector pBEN19. B=BamHI; E=EcoRI; K=KpnI; P=PstI; 4=blunt after treatment with T4 DNA polymerase. RB and LB are right and left border sequences respectively. The ΔATG indicates removal of the ATG startcodon. Figure 2 shows the development of systemic symptoms in transgenic tobacco plants expressing TSWV movement protein (NS M ) sequences. The best performing S 1 lines of the three different groups of transformants are indicated (A2, B3 and C14), as well as some S2 lines derived plants from these S 1 lines that show complete immunity to tomato spotted wilt virus (lines A2-5, B3-13 and C14-14). Plants from a segregant line that lacks transgenic sequences are used as a TSWV -susceptible control. MATERIALS AND METHODS All manipulations involving DNA or RNA are performed according to standard procedures (Sambrook et al. 1989). Viruses and plants The different tospovirus strains, i.e. TSWV strain BR-01, TCSV strain BR-03, and GRSV strain SA-05, have been described by Avila et al. (1990, 1992 and 1993) and are maintained on systemic hosts Nicotiana rustica var. America or N. tabacum var. SRI. Recipient plants used in the transformation experiments are N. tabacum var. SRI plants. All manipulations with transgenic plant material are carried out under conditions (PKII) imposed by the Dutch authorities (VROM COGEM). Construction of ΝS M gene sequence expression vectors NS M gene sequences of TSWV (Kormelink et al. 1992a), are modified in such a way that an EcoRI site is generated immediately downstream of the original startcodon, using primer Zup051 (dGGGAATTCrπTCGGTi\ACAAGAGGCC) located at position 108 to 129 of the viral M RNA and Zup014 (dCCCTGCAGGATCCGAAATTTAAGCTTAAATAAGTG) located at position 1043 to 1023 of the viral complementary M RNA. The resulting PCR fragment is digested with EcoRI and a EcoRI/BamHI linker including an internal Kpnl site and an in frame start codon 5 ' GATCCGGCAACGAAGGTACCATOGG 3 ' 3' GCCGTTGCTTCCATGGTACCCTTAA 5' BamHI Kpnl Ncol EcoRI is ligated. This slightly modified NS M gene (starting with amino acid sequence Met-Leu-De... instead of Met-Thr-Val...) is cloned in a pUC18 vector as a BamHI restriction fragment. The resulting plasmid is linearised using Kpnl, and PstI linkers are ligated after creating blunt ends using T4 DNA polymerase. The 5' to 3' exonuclease activity of T4 DNA polymerase is used to create an untranslatable NS M sequence devoid of its start codon. Different reaction temperatures and incubation times are used to vary the extent of 5' to 3' exonuclease degradation. The resulting clones are checked by sequence analyses and a clone is selected in which the original start codon is mutagenised to CTG. The PstI restriction fragments, i.e. one with an in-frame ATG startcodon and the mutant, are ligated in plant transformation vector pZU-A (Gielen et al. 1991) between the CaMV 35S promoter and the nopaline synthase (nos) terminator. In the pTSWV NS M -A construct, the untranslated leader sequence of TMV (Gallie et al. 1987) is inserted immediately upstream of the NS M gene. In addition, an anti-sense construct is selected. Finally, three NS M constructs are inserted in binary vector pBIN19 (Bevan 1984), yielding pTSWV NS M -A (sense polarity), pTSWV NS M -B (sense/untranslatable) and pTSWV NS M -C (anti-sense polarity). Details of this cloning schedule are presented in Fig.l. Transformation of tobacco Figure 1 shows three constructs containing cDNA sequences derived from the TSWV NS M gene. Construct pTSWV NS M -A contains the NS M gene in a translatable form cloned behind a CaMV 35S promoter supplied with translational enhancing sequences of TMV. Construct pTSWV NS M -B contains the NS M gene of which the original ATG start codon is replaced by CTG. Hereby, a non-translatable form of this gene is created, since the first downstream ATG codon in the NS M sequence is located out of frame, 52 nucleotides downstream of the original ATG which results in the translation of a peptide of only 4 amino acid residues in length. In the pTSWV NS M -C construct NS M sequences are cloned in such a way that an anti-sense RNA with respect to the viral M RNA segment and the NS M mRNA is produced in planta. At the 3' end of all NS M sequences the transcription-termination signal of the nopaline synthase (nos) gene is ligated. Subsequently, the three NS M gene sequence expressor cassettes are each cloned into the binary vector pBIN19. The pBIN19-derived vectors pTSWV NS M -A, pTSWV NS M -B and pTSWV NS M -C are introduced into Agrobacterium tumefaciens strain LB4404 (Ditta et al. 1980) by triparental mating, using pRK2013 (Horsch et al. 1985) as a helper plasmid. N. tabacum var. SRI plants are transformed via A. tumefaciens-mediaxed leaf disk transformation, and the transformants are regenerated as described by Horsch et αl. (1985). Analysis of protection of transgenic plants against TSWV SI progeny seeds are collected from 30 original pTSWV ΝS M -A transformed plants, 26 pTSWV NS M -B transformed plants and 24 pTSWV NS M -C plants. Resulting 80 SI lines are assayed for resistance to TSWV and all resistant plants are maintained for seed production. Twenty plants from the S2 progeny lines are subsequently inoculated with TSWV. Finally, plants from TSWV resistant S2 lines are also challenged with tospoviruses TCSV and GRSV. Inoculations are performed according to standard procedures (Gielen et αl. 1991). The appearance of systemic symptoms is monitored on a daily basis until day 35 after inoculation. Plants are scored susceptible when leaves younger than the inoculated leaf showed characteristic tospovirus induced symptoms i.e. severe stunting and chlorosis, usually followed by death of the plant within a week. Le.af samples from visually healthy plants are collected to check for the presence of the NS S gene product by ELISA, using a polyclonal antisera directed against TSWV NS S protein (Kormelink et al. 1991). This antiserum recognizes the NS S proteins of established tospoviruses TSWV, TCSV and GRSV. Resistance levels in transgenic tobacco plants In total, 93 transformed plants are obtained that express NS M -derived sequences. Of these plants, 34 contain pTSWV NS M -A sequences, 26 the pTSWV NS M -B insert and 24 transformants are obtained expressing pTSWV NS M -C. All original transformants are maintained for seed production. Twenty plants of the resulting S 1 progenies are subsequently assayed for resistance to TSWV. Resistant plants are maintained for S2 seed production and resulting S2 plants are tested for their ability to resist infection by TSWV. Four of the pTSWV NS M -A transformed plants show virus disease-like symptoms during their development. From the four original transform-ants one plant is unable to set seed, therefore no progeny can be tested. Thirty SI lines, derived from the remaining transformants are tested and four display resistance to TSWV (Table 1). From the progenies of those plants, six lines display complete immunity to TSWV. Table 1: Resistance levels in NS M sequence expressing transgenic tobacco SI plants and S2 progenies SI line #resistant/#tested immune S2 progenies pTSWV NS M -A A2 6/20 4/6 A13 2/20 0/2 A23 5/20 0/5 A30 2/20 2/2 26 others 0/20 - pTSWV NS M -B B3 10/20 4/10 25 others 0/20 - pTSWV NS M -C C14 10/20 3/10 C22 3/20 3/3 22 others 0/20 - Of the 26 SI lines transformed with the pTSWV NS M -B construct, only one shows resistance to the virus, albeit at a considerable level of 50% in the SI generation. In four of the resulting ten S2 lines complete immunity is observed. In two of the segregating pTSWV NS M -C lines resistance levels of up to 50% are observed. Resistance levels of up to 100% (i.e. immunity) are reached in six of the resulting S2 lines. Expression of NS M specific RNA and protein in transgenic plants The transcriptional expression of NS M sequences in all seven SI lines that displayed resistance to the virus (A5, A13, A23, A30, B3, C14 and C22) was checked by Northern blot analysis, using a 32 P-dATP labeled double str∑uided NS M cDNA probe. In all resistant lines, transgenically produced RNA could be detected (results not shown), at a level comparable to that reported previously for resistant N gene sequence expressors (De Haan et al. 1992). In leaf-extracts from pTSWV NS M -A transformed plants, NS M protein could neither be observed by Western blot analyses, nor when ELISA techniques were used. NS M protein, however, was observed in cell wall-enriched fractions derived from some of these plants, indicating that the protein accumulates to low levels in cell wall material. The results given inter alia, in Table 1 above indicate that besides expression of N gene sequences of TSWV, also expression of sequences derived from its NS M gene, the putative tospoviral movement protein gene, are able to confer resistance in transgenic tobacco plants to similar high levels as plants expressing nucleoprotein gene sequences (Gielen et al. 1991; De Haan et al. 1992; Prins et al. 1994). Because of the removal of the original startcodon, and the presence of an out of frame ATG start codon, NS M protein cannot be detected in any of the pTSWV NS M -B lines. The same holds true for the anti-sense expressing pTSWV NS M -C lines. In addition, the majority of pTSWV NS M -A transformed plants do not accumulate detectible amounts of NS M protein. Plants that do express NS M protein to a detectable level always develop morphological aberrations, indicating that high levels of expression of the protein may have a negative effect on the growth of the plant. Only plants that do not express the protein or express protein at undetectably low levels develop normally. The high levels of resistance in plants expressing untranslatable and anti-sense RNA support the view that the transgenically expressed RNA, rather than the protein, confers the observed resistance. Resistance induced by NS M sequences results in immunity to TSWV in the homozygous S2 progeny lines. A number of theories have been proposed for the mechanism of such RNA-mediated resistance. The tr.ansgenically produced RNA may interact with the incoming viral RNA or replicative forms of the virus by an anti-sense mechanism. Another model implies competition between transgenic RNAs -and viral RNAs for essential plant or viral factors involved in virus replication. Although the invention has been particularly described with reference to the production of transgenic tobacco resistant to tospoviral infection, it will be appreciated that the invention is not limited to this Example. In particular, any plant species susceptible to tospoviral infection may be rendered resistant or tolerant according to the present disclosure. Moreover, the method of the invention is, of course, not limited to the use of the precise transformation techniques and constructs disclosed in the Examples. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (A) NAME: Sandoz Ltd (B) STREET: Lichtstrasse 35 (C) CITY: Basel (D) STATE: BS (E) COUNTRY: Switzerland (F) POSTAL CODE (ZIP) : CH-4002 (G) TELEPHONE: 061-324-1111 (H) TELEFAX: 061-322-7532 (A) NAME: Sandoz Patent GmbH (B) STREET: Humboltstrasse 3 (C) CITY: Loerrach (E) COUNTRY: Germany (F) POSTAL CODE (ZIP) : D-79540 (A) NAME: Sandoz Erfindungen Verwaltungs GmbH (B) STREET: Brunnerstrasse 59 (C) CITY: Vienna (E) COUNTRY: Austria (F) POSTAL CODE (ZIP) : A-1235 (ii) TITLE OF INVENTION: Virus resistant or tolerant plants (iii) NUMBER OF SEQUENCES: 5 (iv) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentln Release #1.0, Version #1.25 (EPO) (2) INFORMATION FOR SEQ ID NO: 1: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4821 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: unknown (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Tospovirus (Xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1: AGAGCAATCA GTGCAAACAA AAACCTTAAT CCAGACATCT TGAAATTAAT CACACAACCA 60 TTGTJa-iATCTG GGTAGACATC TAAGATGAGA ATTCTAAAAC TACTAGAACT AGTGGTAAAA 120 GTGAGTCTTT TCACAATTGC CCTGAGTTCT GTTTTGTTGG CATTCTTGAT CTTCAGAGCC 180 ACAGATGCTA AAGTAGAAAT AATTCGTGGA GATCATCCTG AGATTTATGA TGATTCTGCT 240 GAGAATGAGG TACCCACTGC TGCATCGATT CAACGCGJUVG CTATCTTAGA GACTTTAACT 300 AATCTGATGC TAGAATCTCG GACTCCTGGA ACCCGTCAGA TACGAGAAGA AAAATCAACC 60 ATCCCTATTT CTGCTGAGCC AACAACGCAA AAAACAATCT CTGTTTTGGA TCTTCCCAAC 420 AATTGCTTGA ATGCTTCTTC AT AAAATGT GAGATAAAAG GGATATCCAC TTATAATGTT 480 TATTATCAAG TTGAAAACAA TGGTGTCATA TATTCCTGTG TTTCTGATTC AGCAGAAGGT 540 TTAGAAAAAT GTGATAATTC TTTAAATTTG CCAAAGAGAT TCTCCAAAGT CCCGGTTATT 600 CCCAT ACCA AGCTAGACAA GAAAAGACAC TTTTCAGTAG GAGGAAAATT CTTCATTTCA 660 GAAAGCCTGA CACAAGATAA TTATCCTATA ACTTACAACT CATACCCCAC TAATGGAACA 720 GTATCATTAC AAACTGTAAA GTTATCCGGT GACTGCAAAA TAACTAAATC AAACTTCGCA 780 AATCCCTATA CTGTAAGCAT CACTAGCCCT GAGAAGATCA TGGGTTATTT GATAAAAAAA 840 CCTGGTGAAA ATGTGGAACA CAAGGTTATA TCTTTTTCTG GATCAGCAAG TATCACTTTT 900 ACTGAGGAAA TGTTGGATGG TGAACACAAT CTCTTGTGTG GTGACAAATC AGCCAAAATA 960 CCAAAAACAA ACAAAAGAGT CAGAGATTGC ATAATCAAAT ATTCAAAAAG TATTTATAAG 1020 CAAACAGCCT GCATCAATTT TTCTTGGATA AGGTTGATAT TGATAGCTTT GTTGATCTAT 1080 TTCCCTATCC GATGGTTAGT GAACAAGACG ACTAAACCTC TCTTTCTCTG GTATGATCTT 1140 ATGGGCTTGA TTACATACCC TGTCTTATTG CTCATAAATT GCTTATGGAA ATATTTCCCA 1200 TTAAAATGTT CTAACTGCGG CAATCTGTGC ATAGTCACAC ATGAGTGTAC TAAAGTCTGC 1260 ATTTGCAACA AAAGCAAAGC TTCAAAAGAG CATTCTTCAG AGTGTCCCAT ACTATCCAAA 1320 GAAGCAGATC ATGACTACAA CAAACATAAG TGGACTAGCA GGAATGGTT CCATCTAATA 1380 GTGAACACTA AGCTGAGCTT GAGTTTGCTA AAATTTGTGA CCGAAATTTT GATAGGTTTA 1440 GTCATTTTGT CTCAGATGCC CATGTCTATG GCTCAAACAA CCCJVATGTTT GAGTGGATGC 1500 TTTTATGTTC CAGGCTGTCC ATTTTTGGTT ACAAGCAAAT TTGAAAAATG CTCTGAAAAA 1560 GATCAATGTT ACTGCAATGT AAAAGAAGAT AAGATCATAG AGAGTATCTT TGGCACTAAT 1620 ATTGTTATAG AAGGTCCTAA TGATTGCATA GAGAACCAGA ATTGCATTGC ACGCCCATCT 1680 ATTGATAATC TTATAAAATG CAGATTAGGT TGCGAATACC TAGATTTATT CCGAAACAAA 1740 CCTTTGTACA ATGGGTTTTC GGATTATACA GGAAGCTCTT TAGGGTTAAC ATCAGTTGGT 1800 CTGTATGAGG CTAAGAGATT GAGAAATGGT ATAATAGATT CCTATAACCG TCAGGGCAAA 1860 ATTTCTGGAA TGGTTGCCGG AGACTCCTTA AACAAAAACG AAACAAGCAT ACCAGAGAAC 1920 ATTCTGCCCA GGCAATCATT AATCTTTGAT TCTGTTGTAG ACGGGAAATA TAGATATATG 1980 ATAGAACAAT CTCTTTTAGG AGGAGGAGGA ACTATATTCA TGCTAAATGA CAAGACCTCA 2040 GAAACAGCCA AAAAATTTGT GATTTATATC AAAAGTGTGG GAATTCATTA TGAAGTGTCA 2100 GAAAAATATA CGACAGCTCC CATCCAAAGC ACCCACACGG ATTTTTATTC CACTTGTACA 2160 GGAAACTGCG ACACTTGCAG GAAAAATCAA GCTTTAACAG GTTTCCAAGA TTTTTGTGTA 2220 ACACCAACTT CTTATTGGGG ATGTGAAGAA GCTTGGTGTT TTGCAATTAA TGAGGGTGCT 2280 ACATGCGGAT TCTGTCGAAA TATTTATGAT ATGGACAAAT CATACAGAAT TTATTCAGTG 2340 CTTAAGTCAA CTATAGTAGC AGATGTTTGT ATTTCCGGTA TTTTGGGAGG TCAATGCTCA 2400 AGGATTACTG AAGAGGTTCC TTATGAAAAT ACATTGTTTC AAGCTGATAT ACAAGCAGAT 2460 TTGCATAATG ATGGTATCAC TATAGGTGAA CTAATAGCTC ATGGACCCGA CAGTCATATT 2520 TACTCTGGAA ATATTG<-AAA CTTGAATGAT CCTGTGAAAA TGTTTGGTCA TCCACJ-ATTG 2580 ACCCATGATG GAGTGCCTAT TTTTACTAAG AAAACTCTAG AAGGAGATGA CATGTCTTGG 2640 GATTGTGCAG CAATAGGGAA aAAAATCAGTC ACTATCAAAA CATGTGGATA CGACACATAC 2700 AGGTTTAGAT CTGGTTTAGA GCAAATATCA GATATTCCTG TTAGTTTCAA AGATTTTTCT 2760 AGTTTTTTTC TGGCAAAATC TTTTAGTCTA GGGAAACTGA AAATGGTAGT TGATCTTCCA 2820 TCTGATCTTT TTAAAGTTGC TCCTAAGAAA CCTTCCATAA CTTCAACAAG CTTaAAATTGC 2880 AATGGCTGTC TTCTATGCGG CCAAGGTTTA TCTTGCCTTT TAGAATTTTT CTCAGATTTG 2940 ACATTTTCTA CTGCAATTTC TATAGATGCT TGCTCTTTAT CTACTTATCA GCTAGCTGTT 3000 AAAAAAGGAT CTJ-iATAAATA CAATATAACA ATGTTTTGTT CAGCCAATCC GGACAAGAAG 3060 AAAATGACAT TGTATCCAGA AGGCAATCCG GATATCTCTG TGGAAGTTTT GGTTAATAAT 3120 GTTATTGTAG AAGAACCAGA GAATATAATA GATCAAAATG ATGAGTATGC TCATGAAGAA 3180 CAACAATATA ATTCTGATTC TTCAGCATGG GGCTTCTGGG ATTATATTAA GAGTCCATTC 3240 AATTTCATTG CAAGTTACTT TGGCTCATTT TTTGATACTA TCAGAGTGGT ACTGCTTATT 3300 GCATTCATTT TTCTTGTGAC TTATTTCTGT TCTATTCTGA CATCCATTTG TAAAGGATAT 3360 GTAAAGAATG AATCTTATAA ATCTAGATCC AAGATAGAGG ATGATGATGA ACCTGAGATC 3420 AAAGCCCCTA TGTTAATGAA AGATACAATG ACAAGAAGAA GGCCACCTAT GGATTTCTCT 3480 CACCTTGTCT GAAGATGCTT GTCACAGATT AAATTTGATT CAATCTTCTA TATTAGCAGG 3540 ATTATATATA TAGAAAAATC TTTAAAATCA ATCATTAACT AATAAAAACG AAATATAAAA 3600 TAAACAAAAA ACAAACAAAA AAATAAAAAT AAACAAAAAA CAACAAAAAA AGTCTTCGGA 3660 CCAAAGTTTG CTTTTCAGCC TTATTTTGTT TTTGTTTTTT GGTTTGATTT TTTGTTTTTT 3720 TCTCTTTTTT GTTTTCGTTT TTTGTTTGGG TTTTTGGATT CAAAATGCAA AATAGACAGA 3780 AATTTAAGCT TAAATAAGTG ATATTTAAAG AACTATATTT CATCAAAGGA TAACTGAGCA 3840 ACACTGTCAG AAATTCCTTC CTCTTCCTCT TCAACTGATC TCTCAAGATT TGAGCTCAGT 3900 TCTTTAAGCT GTTTTTTTAT CTGCTTCTCA CTGTTTCCTT TAGGAATTAT CAGCTTGCAG 3960 GCTTCAATGA ATGCCTGAGA TCTAGCTCTA ATGGCCCTGT TTAGAGGTAT AACCATACAA 4020 CTTTTGTCTT TATCAGCTCT GGGTGAATCA CCAAACTCTT TTGTCCAAGA ATACATGACA 4080 CTACCAAAAG AAACCCCTTT CTTGTATTCT TGGCTACACA TCAAATGCAG CTGACAACAG 4140 TTTTCTGGGG TGTTGTTCAT CTTCGGAATA GACCAGTTCA GATAAAAAAC AAAGCAGATA 4200 GGATCAGTTA TTGTCCCCTG ACCCTTCAGG ATGACTTGCT TTCCAGATGG CATGTTGGGA 4260 TCAATTAAAG CAACCACAAG TTTTCCTGTA GGGTTTGGTA TAGTGGGGCA GACCCATATC 4320 ACAATTCTGG AAATCATCAT GTATTGTTTT CTGCTGTCCC AAGTCGGACA GATCTTGATA 4380 ACCTTATTAG CATTTTGCTT TCCGTTGCCA ACAAAAAGAT CATTTTTCCA GTTTGAGATA 4440 TGATGGTTTG TATCTACTAT CATTCTAGCA GAAAGATCAT AACCTTCTGA CTCTGTGATG 4500 GAATCAGATT CATAGGTTCC AAAGGAAGAT GTTCCCTCAA TGTTTJ^ACAG TATCTTTCCT 4560 TTGGATGCAT CCATGGCTTT GGTTJ-iAAGCA AGCTTTTCAT CAGAAGAAGA CCATGGTTTT 4620 GAGACTTCAA CACTGCCATT ATGTTTAGCA AGTGAAACTA AAGGACCTTC ATCCTTTCCG 4680 GCAGACTTAG AAGGCCTCTT GTTACCGAAA AGAGTCAACA TTTCGAGTTC AACAGCCTAA 4740 GGTAGAGGAG CTTGTGTAAT GTAGTTGATT GATTCTTAGC AAAATGTATA ATAGGTATAT 4800 TTCTGATGCA CTGATTGCTC T 4821 (2) INFORMATION FOR SEQ ID NO: 2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: both (D) TOPOLOGY: unknown (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: primer (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: GGGAATTCTT TTCGGTAACA AGAGGCC 27 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 35 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: both (D) TOPOLOGY: unknown (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: primer (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: CCCTGCAGGA TCCGAAATTT aAAGCTTAAAT AAGTG 35 (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: both (D) TOPOLOGY: unknown (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: primer (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: GATCCGGCAA CGAAGGTACC ATGGG 25 (2) INFORMATION FOR SEQ ID NO: 5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: both (D) TOPOLOGY: unknown (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: primer (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5: GCCGTTGCTT CCATGGTACC CTTAA 25 REFERENCES Avila, A. de, Huguenot, C, Resende, R. de O., Kitajima, E.W., Goldbach, R.W., & Peters, D. (1990) J. Gen. Virol. 71 pp2801-2807. Avila, A.C. de, De Haan, P., Smeets, M.L.L., Resende, R. de O., Kormelink, R., Kitajima, E.W., Goldbach, R.W., and Peters, D. (1992) Arch. Virol. 128 pp211-227. Avila, A.C. de, De Haan, P., Kormelink, R., Resende, R. de O., Goldbach, R.W., and Peters, D. (1993) J. Gen. Virol. 74 ppl53-159. Bevan, M. (1984) Nucl. Acids Res. 12 pp8711-8722. Ditta, G., Stanfield, S., Corbin, D., and Helsinki, D.R. (1980) Proc. Natl. Acad. Sci. USA 77 pp7347-7351. Gallie, D.R., Sleat, D.E., Watts, J.W., Turner, P.C. (1987) Nucl. Acids Res. 15 pp8693- 8711. Gielen, J.J.L., De Haan, P., Kool, A.J., Peters, D., Van Grinsven, M.Q.J.M., and Goldbach, R.W. (1991) Bio Technology 9 ppl363-1367. Horsch, R.B., Fry, J.E., Hoffmann, N.L., Eichholtz, D., Rogers, S.G. and Fraley, R.T. (1985) Science 227 pp 1229- 1231. Kormelink, R., Kitajima, E.W., De Haan P., Zuidema, D., Peters, D., and Goldbach R. (1991) Virology 181 pp459-468. Kormelink, R., De Haan, P., Meurs, C, Peters, D. and Goldbach, R. (1992) J. Gen. Virol. 73 pp2795-2804. Kormelink, R., De Haan, P., Peters, D., and Goldbach, R. (1992) J. Gen. Virol. 73 pp687-693 Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) in "Molecular cloning: A laboratory manual", 2nd ed. (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory).

Claims: CLAIMS 1. A recombinant polynucleotide, comprising a transcriptional regulatory region and a region contiguous therewith and under the transcriptional control thereof, wherein the contiguous region comprises the sequence depicted in Seq ID No. 1 or a sequence complementary thereto or a part of the sequence or complement, characterized in that the sequence, complement or part is modified (i) by removal therefrom of translational-start encoding codons, or mutation of such codons so that they do not encode translational start or stop codons; or (ii) by insertion or deletion of nucleotides 3' of the translational start encoding codon so that the translational reading frame of the thus encoded RNA is different to that of the unmodified sequence, complement or part. 2. A polynucleotide according to claim 1, wherein the mutation in (i) consists of base replacement. 3. A polynucleotide according to either of claims 1 or 2, wherein the contiguous region comprises nucleotides 3813 to 4721 in SEQ ID. No. 1 or the complement thereof or a part of the sequence or complement. 4 A polynucleotide according to any preceding claim, wherein in the contiguous region, the sequence depicted in SEQ ED No. 1 from nucleotides 3813 to 4721 has been modified so as to comprise codons other than those present in the unmodified sequence, with the proviso that in the modified sequence, the amino acids specified by such codons are the same as those specified by the codons in the un-modified sequence. 5 A nucleotide sequence which is complementary to one which hybridizes under stringent conditions with the contiguous region of any one of claims 1 to 4. 6. RNA which is encoded by the contiguous region of the polynucleotide according to any one of claims 1 to 4 or the nucleotide sequence according to claim 5. 7. A DNA construct comprising the polynucleotide of any one of claims 1 to 4 or the nucleotide sequence according to claim 5. 8. A biological vector comprising the polynucleotide according to any one of claims 1 to 4, the nucleotide sequence according to claim 5 or the construct of claim 7. 9. Transformed plant cells containing the polynucleotide according to any one of claims 1 to 4, the nucleotide sequence according to claim 5, the construct of claim 7 or the vector according to claim 8 10. A method of rendering plants resistant or tolerant to infection by tospoviruses comprising the steps of transforming regenerable plant material with a recombinant polynucleotide comprising a transcriptional regulatory region and a region contiguous therewith -and under the transcriptional control thereof and regenerating the thus transformed material into morphologically normal fertile plants, wherein the recombinant polynucleotide comprises as its contiguous sequence, the sequence depicted in SEQ ID No. 1 or a sequence complementary thereto or a part of the sequence or its complement. 11. A method according to the preceding claim, wherein the material is transformed with the polynucleotide according to any one of claims 1 to 4, the nucleotide sequence according to claim 5, the construct of claim 7 or the vector according to claim 8. 12. A method according to either of claims 10 or 11, wherein the said normal fertile plants are selfed to yield products from which are selected those that exhibit resistance or tolerance to tospoviral infection thereby yielding a substantially homogeneous line with respect to this trait, and optionally crossing individuals of the said line, or the progeny thereof, with plants optionally exhibiting the said trait. 13. A method according to the preceding claim, wherein the selfing and selection steps are repeated at least five times in order to obtain the homogeneous line. 14. A method according to any one of claims 10 to 13, wherein the contiguous sequence is bounded by a plant effective transcriptional promoter and terminator, so that the promoter and terminator control tr.anscription of the sequence or complement when it is incorporated into a plant genome. 15. A method according to any one of claims 10 to 14, wherein the polynucleotide according to any one of claims 1 to 4, the nucleotide sequence according to claim 5, or the construct of claim 7 is introduced into the plant material via: a bacterial or viral vector; by micro-injection; by co-incubation of the plant material and polynucleotide, sequence or construct in the presence of a high molecular weight glycol; or by coating of the polynucleotide, sequence or construct onto the surface of biologically inert particle which is then introduced into the material. 16. Use of a recombinant polynucleotide comprising the sequence depicted in SEQ ID No. 1 or a sequence complementary thereto or a part of said sequence or complement in the manufacture of virus resistant or tolerant plants. 17. Use of the polynucleotide according to any one of claims 1 to 4, the nucleotide sequence according to claim 5, the construct of claim 7 or the vector according to claim 8 in the manufacture of virus resistant or tolerant plants. 18. A plant having stably integrated and expressed within its genome, a recombinant polynucleotide comprising the sequence depicted in SEQ ID No. 1 or a sequence complementary thereto or a part of said sequence or complement. 19. A plant having stably integrated and expressed within its genome, the polynucleotide according to any one of claims 1 to 4, or the nucleotide sequence according to claim 5. 20. The progeny of plants according to either of claims 18 or 19, which contain the contiguous sequence stably incoiporated and hereditable in a Mendelian manner, and/or the seeds of such plants or such progeny. 21. The use in the manufacture of plant varieties of totipotent transformed cells according to claim 9, plants according to either of claims 18 or 19, or the seeds or progeny according to claim 20. 22. A microbiological process for making virus tolerant or resistant plants, including varieties thereof, comprising the steps of: (i) transforming regenerable plant material with a recombinant polynucleotide and regenerating the thus transformed material into morphologically normal fertile plants; and (ii) optionally crossing the plants resulting from (i) with plants which are not the product of (i); characterized in that the recombinant polynucleotide comprises the sequence depicted in SEQ ID No. 1 or a sequence complementary thereto or a part of the sequence or its complement. 23. A microbiological process for making virus tolerant or resistant plants, including varieties thereof, comprising the steps of: (i) transforming regenerable plant material and regenerating the thus transformed material into morphologically normal fertile plants; and (ii) optionally crossing the plants resulting from (i) with plants which are not the product of (i); characterized in that the plants are transformed with the polynucleotide according to any one of claims 1 to 4, the nucleotide sequence according to claim 5, the construct of claim 7 or the vector according to claim 8. 24. A process according to either of claims 22 or 23, wherein the said normal fertile plants are selfed to yield products from which are selected those that exhibit resistance or tolerance to tospoviral infection thereby yielding a substantially homogeneous line with respect to this trait, and crossing individuals of the said line, or the progeny thereof, with plants optionally exhibiting the said trait. 25. A method according to the preceding claim, wherein the selfing and selection steps are repeated at least five times in order to obtain the homogeneous line.

Inventors: DE HAAN PETRUS THEODORUS, DE HAAN, PETRUS, THEODORUS
Applicants: HAAN PETRUS THEODORUS DE, SANDOZ AG, SANDOZ LTD, DE HAAN, PETRUS, THEODORUS, SANDOZ LTD., SANDOZ-ERFINDUNGEN VERWALTUNGSGESELLSCHAFT MBH, SANDOZ-PATENT-GMBH
Application year: 1996
Main classification: C12N15
IPC codes: C12N15